June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Leidos & 3 Contractors Win $480M Deal To Curb Drug Traffic

Published 09/20/2016, 11:13 PM
Updated 07/09/2023, 06:31 AM
LMT
-
LDOS
-
DCO
-
EGL
-

Leidos Holdings, Inc. (NYSE:LDOS) , a renowned technology services and solutions provider, was among other three contractors that recently won a contract for offering technical solutions to the U.S. Department of Defense Counter-Narcoterrorism Technology Program Office (CNTPO). Valued at $480 million, the contract was awarded by the U.S. Army Space and Missile Defense Command.

What’s CNTPO?

The CNTPO is the leading developer of inter-agency and multinational operations to disrupt, deter and deny narcoterrorist activities so as to reduce trafficking of illegal narcotics and materials that support global terrorist activities.

Details of the Contract

As per the terms of the contract, Leidos will provide technical solutions and mission support for command, control, communications, information, detection and monitoring technology and systems in order to counter national security threats posed by drug trafficking, piracy and transnational organized crime. These solutions will also bring down finance networks related to illicit drug trafficking activities. The contract is expected to allow the CNTPO to limit, if not completely stop, international drug trafficking.

Our View

In the second quarter of 2016, Leidos recorded a 4% year-over-year increase in revenues to $915 million at the National Security Solutions (NSS) business segment. Segment bookings amounted to $520 million. For the third quarter, management forecasts an increase in bookings on the back of several anticipated award decisions, as well as typical seasonality at the end of the government fiscal year.

Being a prominent provider of advanced technical solutions in a number of markets including defense, intelligence, homeland security, civil, and health, surely the latest contract will boost the company’s NSS segment.

Meanwhile, in a bid to strengthen its technical services solutions, Leidos completed its merger with defense giant Lockheed Martin Corp.’s (NYSE:LMT) Information Systems & Global Solutions business (IS&GS) last month. This combination is expected to have brought together a $10 billion portfolio of solutions, mission IT, and technical services under Leidos’ control, to which the aforementioned contract seems like a meaningful upgrade.

Zacks Rank & Stocks to Consider

Leidos Holdings currently carries a Zacks Rank #2 (Buy), while Lockheed Martin has a Zacks Rank #4 (Sell). A few favorably placed stocks in the aerospace and defense sector include Engility Holdings, Inc. (NYSE:EGL) and Ducommun Inc. (NYSE:DCO) , both of which sport a Zacks Rank #1 (Strong Buy).You can see the complete list of today’s Zacks #1 Rank stocks here.

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



LOCKHEED MARTIN (LMT): Free Stock Analysis Report

DUCOMMUN INC DE (DCO): Free Stock Analysis Report

ENGILITY HLDGS (EGL): Free Stock Analysis Report

LEIDOS HOLDINGS (LDOS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.